-Adrenoceptor agonists and asthma-100 years of development

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.445, Iss.1, 2002-06, pp. : 1-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase 4 and tolerance to 2 -adrenoceptor agonists in asthma

By Giembycz M.A.

Trends in Pharmacological Sciences, Vol. 17, Iss. 9, 1996-09 ,pp. : 331-336

Elsevier

Access to resources Recommend Favorite

Long-Acting 2-Adrenoceptor Agonists and Exercise-Induced Asthma: Lessons to Guide Us in the Future

By Anderson Sandra D. Brannan John D.

Pediatric Drugs, Vol. 6, Iss. 3, 2004-01 ,pp. : 161-175

Adis International

Access to resources Recommend Favorite

Ultra-Long-Acting β2-Adrenoceptor Agonists: An Emerging Therapeutic Option for Asthma and COPD?

By Maria Gabriella Matera

Drugs, Vol. 67, Iss. 4, 2007-01 ,pp. : 503-515

Adis International

Access to resources Recommend Favorite

-adrenoceptor agonists increase cardiovascular risk

Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

New action for -agonists in asthma

Inpharma, Vol. 1, Iss. 1401, 2003-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite